Relmada Therapeutics (RLMD) Market Capitalization (2014 - 2026)
Relmada Therapeutics (RLMD) reported Market Capitalization of $738.16 million for Q2 2026, compared with $19.91 million a year earlier and up 22.5% from the prior quarter.
Powered by 
Analysis
Relmada Therapeutics (RLMD) Market Capitalization (2014 - 2026) Analysis & Trends
For FY2025, Relmada Therapeutics posted Market Capitalization of $190.69 million.
- Market Capitalization has a five-year compound annual growth rate of -18.3% (FY2020 to FY2025).
- By year, Market Capitalization came in at $15.69 million in FY2024 (-87.4%), $124.61 million in FY2023 (+18.6%), $105.05 million in FY2022 (-73.4%) and $395.46 million in FY2021 (-24.5%).
- The Q2 2026 figure ranks as the highest quarterly Market Capitalization since Q3 2022.
- Year over year, Market Capitalization gained in 1 of the last five quarters, with an average decline of 56.5%.
- The high point for year-over-year Market Capitalization in five years was Q3 2022 (growth of 131.2%); the low point was Q1 2025 (a decline of 93.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $602.71 million (Q1 2026), $190.69 million (Q4 2025) and $66.72 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Relmada Therapeutics | 473.10 Mn | -85.48 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 738.16 Mn |
| Mar 31, 2026 | 602.71 Mn |
| Dec 31, 2025 | 190.69 Mn |
| Sep 30, 2025 | 66.72 Mn |
| Jun 30, 2025 | 19.91 Mn |
| Mar 31, 2025 | 8.96 Mn |
| Dec 31, 2024 | 15.69 Mn |
| Sep 30, 2024 | 97.76 Mn |
| Jun 30, 2024 | 90.52 Mn |
| Mar 31, 2024 | 140.31 Mn |
| Dec 31, 2023 | 124.61 Mn |
| Sep 30, 2023 | 90.30 Mn |
| Jun 30, 2023 | 74.04 Mn |
| Mar 31, 2023 | 68.02 Mn |
| Dec 31, 2022 | 105.05 Mn |
| Sep 30, 2022 | 1.06 Bn |
| Jun 30, 2022 | 570.17 Mn |
| Mar 31, 2022 | 473.75 Mn |
| Dec 31, 2021 | 395.46 Mn |
| Sep 30, 2021 | 458.72 Mn |
API Access
Relmada Therapeutics Market Capitalization API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=market-capitalization&ticker=RLMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "market-capitalization", "ticker": "RLMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=market-capitalization&ticker=RLMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();